A panel advising the Food and Drug Administration said AquaBounty Technologies' biotech salmon would be safe for human consumption and seem to pose no safety risk to the environment. However, some members of the committee said they found some flaws in the studies that back the safety of the biotech fish, including the small number of fish tested. The FDA was set to hold a public hearing today to discuss whether biotech salmon should carry a label signifying genetic modification.

Related Summaries